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Abstract
A number of mammalian antimicrobial proteins produced by neutrophils and cells of epithelial origin
have chemotactic and activating effects on host cells, including cells of the immune system.
Eosinophil granules contain an antimicrobial protein known as eosinophil-derived neurotoxin
(EDN), which belongs to the RNase A superfamily. EDN has antiviral and chemotactic activities in
vitro. In this study, we show that EDN, and to a lesser extent human pancreatic RNase (hPR), another
RNase A superfamily member, activates human dendritic cells (DCs), leading to the production of
a variety of inflammatory cytokines, chemokines, growth factors, and soluble receptors. Human
angiogenin, a RNase evolutionarily more distant to EDN and hPR, did not display such activating
effects. Additionally, EDN and hPR also induced phenotypic and functional maturation DCs. These
RNases were as efficacious as TNF-α, but induced a different set of cytokine mediators. Furthermore,
EDN production by human macrophages could be induced by proinflammatory stimuli. The results
reveal the DC-activating activity of EDN and hPR and suggest that they are likely participants of
inflammatory and immune responses. A number of endogenous mediators in addition to EDN have
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been reported to have both chemotactic and activating effects on APCs, and can thus amplify innate
and Ag-specific immune responses to danger signals. We therefore propose these mediators be
considered as endogenous multifunctional immune alarmins.
Mammalian antimicrobial proteins are important for innate host defense (1). Many of these
proteins also have stimulating effects on cells of the immune system (2,3). Human
antimicrobial proteins stored in neutrophil granules, such as α-defensins and cathelicidins, are
chemotactic for distinct subsets of leukocytes (4–7). The β-defensins, predominantly produced
by epithelial cells and keratinocytes, act as chemoattractants for immature dendritic cells
(iDCs),3 memory T cells, mast cells, and macrophages (8–12). Additionally, defensins and
cathelicidins activate diverse types of leukocytes and epithelial cells, resulting in degranulation,
and release of various mediators including cytokines and chemokines (13–16). In murine
experimental models, neutrophil granule-derived α-defensins and epithelial cell-derived β-
defensins have been demonstrated to enhance Ag-specific immune responses when
administered together with Ags or as Ag-defensin fusion conjugates (9,16,17).
Human eosinophil granules contain four major cationic proteins, two of which, namely
eosinophil-derived neurotoxin (EDN) and eosinophil cationic protein (ECP), are members of
the RNase A superfamily. Based on their evolutionary relationship, the RNase A superfamily
has been classified into five subfamilies: the eosinophil-associated RNases (EARs), including
human EDN and human ECP, the pancreatic-type RNases (PRs), the RNase 4s, the angiogenins
(ANGs), and the RNases from the bullfrog Rana, including onconase (18). They are
characterized by a specific disulfide-bond structure that is crucial for the relative positioning
of amino acid residues contributing to the catalytic site, and they all function to varying degrees
in endo- and/or exonucleolytic cleavage of polymeric RNA (18). In addition to their common
RNase activity, members of the RNase A superfamily have been reported to have diverse
biologic actions, including antitumor, antimicrobial, and angiogenic properties (18–20).
Of the two human EARs, EDN is less cationic (pI ≈ 8) than ECP and has no cellular toxicity,
except for that observed against rabbit Purkinje cells, which accounts for its unusual name
(18,21). EDN was cloned in 1989 (22), and its x-ray crystallographic structure was elucidated
in 1996 (23). EDN was shown to have in vitro antiviral activity against respiratory syncytial
virus in 1998 (24), thus marking EDN as a host gene-encoded antimicrobial protein. In addition,
EDN has also been shown to be responsible in part for the anti-HIV-1 activity found in the
supernatant of MLCs (25).
Very recently, we have shown that EDN functions as a selective chemoattractant for dendritic
cells (DCs) (26). Because certain mammalian antimicrobial proteins that are chemotactic for
leukocytes can induce the activation of leukocytes (2,3,9,16), the initial aim of this study was
to examine whether a variety of DC chemotactic antimicrobial proteins, including EDN, could
serve as activators for DCs. Using a very sensitive Ab-based microarray capable of quantifying
numerous soluble mediators (including cytokines, chemokines, growth factors, and soluble
receptors) (27), we found that, among several chemotactic antimicrobial proteins tested, EDN
was as capable as TNF-α in inducing soluble mediator production by DCs. To our surprise,
human PR (hPR) (intended as a negative control for EDN) was also active in this respect. EDN
and hPR not only stimulated the production of many soluble mediators by DCs, but were also
capable of inducing the maturation of DCs. EDN is not only produced by eosinophils, its
3Abbreviations used in this paper: iDC, immature dendritic cell; ANG, angiogenin; CM, chemotaxis media; DC, dendritic cell; EAR,
eosinophil-associated RNase; ECP, eosinophil cationic protein; EDN, eosinophil-derived neurotoxin; GPCR, Giα protein-coupled
receptor; hANG, human ANG; hPR, human pancreatic-type RNase; IP-10, IFN-γ-inducible protein-10; mEAR, murine EAR; MIG,
monokine induced by IFN-γ; PR, pancreatic-type RNase; RCA, rolling-circle amplification; SLC, CCL21/secondary lymphoid tissue
chemokine.
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expression by macrophages was induced by a combination of TNF-α and LPS. These results
demonstrate that EDN and hPR, two closely related RNase A superfamily members, can act
as endogenous activators of Ag-presenting DCs.
Materials and Methods
Reagents
Recombinant human TNF-α, GM-CSF, M-CSF, IL-4, Flt3-L, stem cell factor, thrombopoietin,
RANTES, and CCL21/secondary lymphoid tissue chemokine (SLC) were purchased from
PeproTech (Rocky Hill, NJ). FITC-conjugated goat anti-mouse IgG Ab, BSA, and LPS
(Escherichia coli, serotype O55:B5) were from Sigma-Aldrich (St. Louis, MO). [3H]TdR
(specific radioactivity = 2 Ci/mmol) was purchased from NEN (Boston, MA). Human ANG
(hANG) was purchased from R&D Systems (Minneapolis, MN). IMDM was purchased from
Invitrogen Life Technologies (Rockville, MD). RPMI 1640, glutamine, penicillin,
streptomycin, and HEPES were from BioWhittaker (Walkersville, MD). FBS was purchased
from HyClone (Logan, UT). mAbs against human CD11c, CD14, CD40, CD83, CD86, and
HLA-DR and isotype-matched control Abs were purchased from BD Pharmingen (San Diego,
CA).
The genes coding for human EDN or hPR were cloned into the vector, pET-11d (Novagen,
Madison, WI) (28), and expressed in BL21 (DE3) E. coli cells (Novagen), as described (29).
Recombinant proteins were isolated from inclusion bodies, denatured, renatured, and dialyzed
against 20 mM Tris-HCl, pH 7.5, containing100 mM urea before application to a heparin-
Sepharose column (Amersham Biosciences, Piscataway, NJ) for human rEDN or a chemotaxis
medium (CM)-Sephadex C-50 column (Amersham Biosciences) for rhPR using 2 ml of the
respective resin per liter of dialyzed protein. Following elution from the respective columns
with 20 mM Tris-HCl, pH 7.5, containing 10% glycerol and 0.5 M NaCl, the proteins were
dialyzed vs 20 mM Tris-HCl, pH 7.5, 5% glycerol, lyophilized, resuspended in H2O, and
applied to a Sephadex G100 column (Amersham Biosciences) equilibrated and eluted with 20
mM Tris-HCl, pH 7.5, containing 10% glycerol. Fractions containing the proteins of interest
were pooled, dialyzed, lyophilized, and stored as a dry powder at −20°C. Natural human EDN
was purified from commercial preparations of human urinary gonadotrophin, as described
(30). Briefly, resuspended urinary gonadotrophin preparations were dialyzed extensively at 4°
C against 50 mM Tris (pH 8.0) + 1 mM NaCl, and were then fractionated by heparin-Sepharose
column chromatography (Amersham Biosciences) using a salt-gradient (1 mM to 1 M NaCl
in 50 mM Tris, pH 8.0) for the elution. The fractions containing EDN were pooled, concentrated
(Centricon 10; Millipore, Beverly, MA), and subjected to purification by Superdex 200
(Amersham Biosciences) chromatography. The concentration of purified EDN and
recombinant proteins was determined by bicinchoninic acid assay (Pierce, Rockford, IL).
Limulus amebocyte lysate assay
The endotoxin level in the various RNase samples was measured by the use of Limulus
Amebocyte Lysate Pyrogent test kit (BioWhittaker) following the manufacturer’s protocol.
The sensitivity of the test kit for endotoxin was 0.06 IU/ml.
Isolation, purification, and preparation of cells
Human PBMC were isolated by Ficoll density gradient centrifugation from leukopacks
supplied by the Department of Transfusion Medicine (Clinical Center, National Institutes of
Health, Bethesda, MD). Monocytes were purified (>95%) from human PBMC with MACS
CD14 monocyte isolation kit (Miltenyi Biotec, Auburn, CA). Human cord blood CD34+
progenitors (>90%) were purchased from Cambrex (Walkersville, MD). The DC precursors
were amplified from CD34+ hemopoietic progenitor cells by culturing the cells at 5 × 104 cells/
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ml in IMDM supplemented with 20% FBS, 10−5 M DTT, 25 ng/ml Flt3-L, 10 ng/ml TPO, and
20 ng/ml stem cell factor for 4 wk (31). The amplified DC precursors were cryopreserved in
IMDM containing 20% FBS and 10% DMSO for later usage.
Macrophages were generated by incubating purified human peripheral blood monocytes (1 ×
106/ml) in the presence of M-CSF, as described previously (32). Macrophages were treated in
the absence or presence of TNF-α (100 ng/ml) and LPS (100 ng/ml) for a period of time, as
specified.
DC culture
DCs were generated, as described previously (31,32). In brief, monocyte-derived iDCs were
generated by incubating purified monocytes at 1 × 106/ml in G4 medium (RPMI 1640
containing 10% FBS, 2 mM glutamine, 25 mM HEPES, 100 U/ml penicillin, 100 μg/ml
streptomycin, 50 ng/ml GM-CSF, and 50 ng/ml IL-4) at 37°C in a CO2 (5%) incubator for 7
days. To generate CD34+ hemopoietic progenitor cell-derived iDCs (CD34-iDCs), the
amplified DC precursors were cultured in G4 medium for 48 h at 37°C in a CO2 (5%) incubator.
All of the cultures were fed with the same cytokine-containing medium every 2–3 days.
To examine the effect of various RNase samples on DCs, iDCs were suspended at 1 × 106/ml
in G4 medium alone or in the presence of various samples at concentrations as specified, and
incubated at 37°C in a CO2 (5%) incubator for indicated periods of time. Subsequently, the
culture supernatants and/or the cells were collected and analyzed.
ELISA
IL-6, IL-12p70, TNF-α, IFN-γ-inducible protein-10 (IP-10), RANTES, MCP-2, and MIP-1α
in the culture supernatants were measured by Pierce using MultiPlex ELISA kits. The
concentrations of IL-6, TNF-α, and MIP-1α in some culture supernatants were measured using
ELISA kits purchased from R&D Systems strictly following the protocols provided by the
manufacturer.
Microarray manufacture and rolling-circle amplification (RCA) immunoassay
Ab microarrays were printed using a bicinchoninic acid-II piezoelectric microarray dispenser
(Packard Biosciences, Downers Grove, IL) on cyanosilane-coated glass slides divided by
Teflon boundaries into sixteen 0.5-cm-diameter circular subarrays. mAbs for 78 analytes were
dispensed in quadruplicate at a concentration of 0.5 mg/ml. Printed slides were blocked, as
described previously (27), and stored at 4°C until use. Batches of slides were subjected to a
quality control consisting of incubation with a fluorescent-labeled anti-mouse Ab, followed by
washing, scanning, and quantitation. Typically, the coefficient of variability of Ab deposition
in printing was <5%.
The RCA immunoassay was performed by a liquid-handling Biomek 2000 robot (Beckman
Coulter, Fullerton, CA), which was enclosed in 80% humidified, high efficiency particulate
air-filtered, plexiglass chamber. For each sample, duplicates were tested either undiluted or
diluted at 1/10. A total of 20 μl of samples was applied to each subarray, and RCA immunoassay
was performed, as previously described (27). Slides were scanned by the use of GenePix (Axon
Instruments, Foster City, CA) at 10 μm resolution with a laser setting of 100 and photomultiplier
tube setting of 550. Mean pixel fluorescence was quantified using the fixed circle method in
GenePix Pro 3.0 (Axon Instruments). The fluorescence intensity of eight microarray features
(duplicate subarrays and quadruplicate spots in each subarray) was averaged for each feature
and sample, and the resulting cytokine values as Cy5 intensity were determined. For each slide,
a set of blanks was run as a negative control. Analyses were performed using the levels of all
78 analytes (cytokines, chemokines, growth factors, and soluble receptors) measured in relative
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fluorescent intensity units or by fold increase for the purpose of comparison. Sensitivity of
RCA immunoassay was femtomolar (27,33): 46 (60%) of the 78 analytes had a sensitivity of
≤10 pg/ml, 24 (30.8%) had a sensitivity of ≤100 pg/ml, 5 (6.4%) had a sensitivity of ≤1 ng/ml,
and 3 (3.8%) had a sensitivity of ≤10 ng/ml. The dynamic range (~3 orders of magnitude) and
precision of RCA immunoassay were similar to unamplified immunoassays (27,33).
RNA extraction and RT-PCR
Total RNA was isolated from macrophages by the use of TRIzol reagent (Invitrogen Life
Technologies), according to the manufacturer’s recommendation. The RNAs were treated with
RNase-free DNase I (Stratagene, La Jolla, CA) at 37°C for 30 min to eliminate possible
genomic DNA contamination and purified by phenol:chloroform extraction and ethanol
precipitation. The concentration and purity of RNA samples were examined by measuring their
absorbance at 260 and 280 nm, and the integrity of RNA samples was confirmed by agarose
gel electrophoresis. All of the RNA samples used were pure (A260/280 > 1.8) and without
degradation. The EDN mRNA expression by macrophages was measured by RT-PCR by the
use of GeneAmp kit (Invitrogen Life Technologies). Briefly, total RNA was reverse transcribed
in a volume of 20 μl. Subsequently, the reverse-transcription product was divided in half and
used for the amplification of EDN or GAPDH by 35 cycles of PCR (denature at 95°C for 30
s, annealing at 55°C for 30 s, and extension at 72°C for 1 min) with the last extension being
performed at 72°C for 10 min. The sense and antisense primers for EDN were 5′-
TCTCACAGGAGCTACAGCGCG-3′ (nt 326~346, exon 1) and 5′-
AACATGTTTGCTGGTGTCTGC-3′ (nt 967~987, exon 2), which enabled the amplification
of a 420-bp EDN-specific cDNA fragment. The primers for human GAPDH were 5′-
GATGACATCAAGAAG GTGGTGAA-3′ and 5′-GTCTTACTCCTTGGAGGCCATGT-3′,
which resulted in the amplification of a fragment of 246 bp. PCR products were identified on
1.8% agarose gel, stained with ethidium bromide, and photodocumented after washing off
excessive dye with water.
Flow cytometry
DCs (106/sample) were first washed three times with FACS buffer (PBS, 1% FBS, 0.02%
NaN3, pH 7.4), and then stained with mouse mAbs against human CD14, CD40, CD83, CD86,
HLA-DR, or isotype-matched control Ab (final concentration of 5 μg/ml) at room temperature
for 30 min. After washing three times with FACS buffer, the cells were suspended in FACS
buffer containing FITC-conjugated goat anti-mouse IgG for 30 min at room temperature.
Finally, the stained cells were washed twice with FACS buffer, twice with PBS, fixed with 1%
paraformaldehyde in PBS, and analyzed the next day with a flow cytometer (Coulter Epics,
Miami, FL).
Chemotaxis assay
Cell migration was assessed using a 48-well microchemotaxis chamber (32). The cells were
washed three times and resuspended in CM (RPMI 1640 containing 1% BSA). RANTES and
SLC diluted with CM were placed in wells of the lower compartment of the chamber
(NeuroProbe, Cabin John, MA), and DCs suspended in CM at 1 × 106 cells/ml were added into
wells of the upper compartment. The lower and upper compartments were separated by a 5-
μm polycarbonate filter (Osmonics, Livermore, CA). After incubation at 37°C for 1.5 h in
humidified air with 5% CO2, the filters were removed, scraped, and stained. The cells migrated
across the filter were counted with the use of a Bioquant semiautomatic counting system
(Nashville, TN) and presented as the number of cells per high-power field.
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Allogeneic MLR was performed, as described (34). Briefly, purified allogeneic T cells (105/
well) were cultured with different numbers of DCs in a 96-well flat-bottom plate for 7 days at
37°C in humidified air with 5% CO2. The proliferative response of T cells was examined by
pulsing the culture with [3H]TdR (0.5 μCi/well) for the last 8 h before harvesting. [3H]TdR
incorporation was measured with a microbeta counter (PerkinElmer Wallac, Gaithersburg,
MD).
SDS-PAGE and Western blot
Each 20 μg of proteins from the culture supernatants of macrophages treated with TNF-α and
LPS for indicated period of time was mixed with 4× SDS-PAGE sample buffer to achieve a
final concentration of 62.5 mM Tris-HCl (pH 6.8 at 25°C), 2% w/v SDS, 10% glycerol, 50
mM dithiothretol, and 0.01% bromphenol blue in a final volume of 20 ml. The samples were
boiled for 5 min, cooled on ice, loaded (20 μl/lane), and separated on a 4–12% NuPAGE bis-
Tris gel (Invitrogen Life Technologies). SeeBlue Plus2 (Invitrogen Life Technologies) was
used as molecular size marker. After the electrophoresis, proteins in the gel were
electrotransferred (30 V constant for 1 h) onto a piece of Immobilon membrane (Millipore)
with a Xcell II Blot Module (NOVEX, San Diego, CA) using 1× NuPAGE transfer buffer (12
mM Tris, 96 mM glycine, pH 8.3, 0.1% v/v antioxidant, 10% v/v methanol). The Western blot
was conducted at room temperature, unless specified otherwise. The polyvinylidene difluoride
membrane was sequentially washed with 25 ml of 1× TBS for 5 min, incubated for 1 h in 25
ml of blocking buffer (1× TBS, 0.1% Tween 20, 5% w/v nonfat milk, 5 μg/ml human IgG, and
10% FCS), washed three times for 5 min each with TBST (1× TBS, 0.1% Tween 20), and
incubated at 4°C overnight in blocking buffer containing 1/1000 dilution of rabbit anti-EDN
polyclonal Ab (Assay Research, College Park, MD). On the next day, the membrane was
washed three times for 5 min each with 15 ml of TBST and incubated with 10 ml of 1/2000
dilution of HPR-conjugated anti-rabbit IgG (Cell Signaling Technology, Beverly, MA;
catalogue 7074) for 1 h. After washing five times for 5 min each with 15 ml of TBST, the
membrane was incubated with 10 ml of working solution of ECL Plus Detection Reagents
(Amersham, Piscataway, NJ) for 5 min, immediately wrapped with Saran wrap, and exposed
to a piece of BioMax x-ray film (Kodak, Rochester, NY) for 5 s. The x-ray film was developed
using an automatic processor (Kodak X0OMAT 200A).
Statistical analysis
All experiments were performed 2~3 times, and the data of one representative experiment are
shown. The statistical significance of difference between groups was analyzed using paired
Student’s t test.
Results
EDN and hPR induce CD34+ progenitor-derived iDCs to produce inflammatory mediators
Previously, we have shown that EDN is selectively chemotactic for both human and mouse
DCs (26). To evaluate whether EDN could activate DCs, a number of DC chemotactic factors,
including several antimicrobial proteins, were screened for their capacity to stimulate the
production of a dozen prominent inflammatory cytokines and chemokines by human CD34+
progenitor-derived iDCs. Of the DC chemoattractants, EDN treatment of CD34+ progenitor-
derived DCs for 16 h resulted in the induction of all of the cytokines and chemokines measured
by 2- to 36-fold (Fig. 1). In these experiments, hPR was intended to be a negative control
because both the chemotactic and antiviral activities of EDN were not shared by hPR (24–
26). To our surprise, hPR also induced the production of a similar set of inflammatory cytokines
and chemokines (Fig. 1). Other DC chemoattractants, including murine EAR2 (mEAR2),
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showed negligible effects on the production of 12 inflammatory cytokines and chemokines by
CD34+ progenitor-derived DCs (Fig. 1 and data not shown).
EDN and hPR stimulated the production of various mediators by both CD34+ progenitor-
derived and monocyte-derived DCs
To gain a thorough view of DC-produced soluble mediators induced by EDN and hPR, we
investigated the soluble mediators that EDN and hPR stimulated in human DCs using Ab-based
microarrays capable of simultaneously measuring 78 different soluble mediators. Table I
summarizes the induction of soluble mediators by EDN or hPR from both CD34+ progenitor-
derived and monocyte-derived iDCs when treated for 48 h. EDN and hPR treatment of
CD34+ progenitor-derived iDCs induced ≥3-fold increased secretion of 17, and 12 of the 78
soluble mediators, respectively. Monocyte-derived iDCs produced 15 soluble mediators in
response to EDN, while 7 of 78 were induced by hPR (with ≥3-fold increase). Several
characteristics stand out. 1) EDN and hPR preferentially induced mostly proinflammatory
mediators. 2) The soluble mediators induced by hPR largely overlapped with those induced by
EDN; however, hPR appears to be less efficacious than EDN in stimulating soluble mediator
production given the fact that molecular mass of EDN (≈16 kDa) is slightly larger than that of
hPR (≈14 kDa). 3) The profile of soluble mediator induction of CD34+ progenitor-derived
iDCs was similar to that of monocyte-derived iDCs in response to EDN or hPR, with the
exception of three chemokines. CD34+ progenitor-derived iDCs up-regulated epithelial-
derived neutrophil-activating protein (ENA) 78, and MCP-3, but not MIP-1β, whereas
monocyte-derived iDCs showed the reverse. This difference in the production of ENA-78,
MCP-3, and MIP-1β by CD34+ progenitor-derived vs monocyte-derived DCs most likely
reflects one of a few distinctive features between these two populations of DCs (31,35,36).
To further characterize the capacity of EDN and hPR to induce soluble mediator production
by DCs, we investigated their dose-and time-dependent effects. The time course and dose
response of EDN- and hPR-induced production of 10 chemokines and 5 cytokines by CD34+
progenitor-derived DCs are shown in Figs. 2 and 3, respectively. The mediator induction was
dose dependent and peaked at different times. For example, EDN induced MIP-1α, RANTES,
IL-6, IP-10, and MCP-1, and TNF-α maximally at 3~6 h; monokine induced by IFN-γ (MIG),
MCP-2, MCP-3, and IL-12 p70 at 24 h; and neutrophil-activating peptide-2, IL-12 p40, and
M-CSF at 48 h (Figs. 2 and 3A). Although the induction of most cytokines and chemokines by
EDN and hPR was similar, only EDN induced considerable production of MIG and IL-12p70
(Figs. 2 and 3), suggesting that EDN may favor Th1 polarization. Again, EDN was more
efficacious than hPR in the induction of cytokine and chemokine production (Figs. 2 and 3).
EDN- and hPR-induced mediator production by monocyte-derived DCs showed a similar dose
dependence and kinetics (data not shown), indicating considerable similarity between the panel
of mediators produced by the two DC populations generated in vitro in response to EDN and
hPR.
To both confirm and validate EDN induction of inflammatory cytokines and chemokines from
DCs, DCs were generated from either CD34+ progenitors or monocytes of various healthy
individuals, treated with or without EDN for 24 h, and the production of seven inflammatory
mediators (which were shown to be induced by EDN using the Ab-based microarray
immunoassay) in the culture supernatants was measured by ELISA (Fig. 4). Similar to the
results obtained using the microarray (Figs. 2 and 3), EDN induced the production of IL-6,
IL-12p70, TNF-α, IP-10, RANTES, MCP-2, and MIP-1α from both CD34+ progenitor-derived
and monocyte-derived DCs, as measured by ELISA (Fig. 4), validating both the reliability of
Ab-based microarray assay as well as authenticating stimulation of DC production of cytokines
and chemokines by EDN.
Yang et al. Page 7













Mediator induction by EDN and hPR was not due to endotoxin contamination
Because E. coli-derived EDN and hPR samples were used in most of the experiments, it was
critical to determine whether the observed effect was due to possible endotoxin contamination.
The endotoxin level in EDN and hPR samples used in the present study was below the detection
limit of the Limulus amebocyte lysate assay, indicating <0.6 ng of endotoxin per mg of protein.
The highest concentrations of EDN or hPR used in our experiments were 1 μg/ml, which could
only contain <0.6 pg/ml endotoxin. In addition, heating samples for 30 min at 100°C destroyed
the capacity of EDN or hPR to induce IL-6 production by DCs, while having no significant
effect on the IL-6-inducing capacity of LPS (Fig. 5A). We further compared the spectra of
mediators induced by EDN, hPR, and LPS from CD34+ progenitor-derived iDCs. Although
EDN and hPR induced a similar battery of mediators by CD34+ progenitor-derived iDCs, LPS
stimulates a different set of mediators, half of which were not induced by EDN and hPR (Fig.
5B). Therefore, the effect of EDN or hPR on iDCs was not due to endotoxin contamination.
Both natural and recombinant EDNs exhibit similar cytokine-inducing effects on DCs
Because rEDN generated in E. coli is not glycosylated as is natural EDN, we examined whether
EDN purified from a natural source was also able to induce the production of cytokines and
chemokines. When human CD34+ progenitor-derived iDCs were used, both natural and
recombinant EDNs induced the production of similar amounts of 10 different cytokines (Fig.
6A). We also compared the effects of hANG, hPR, and natural and recombinant EDNs on the
production of five cytokines by monocyte-derived iDCs (Fig. 6B). hPR and EDN (both natural
and recombinant), albeit slightly varied in terms of extent, all induced statistically significant
production of IL-6, IP-10, MCP-2, MIG, and RANTES. In contrast, hANG, although also
belonging to the RNase A superfamily, did not induce cytokine and chemokine production,
indicating that not all members of the RNase A superfamily share the capacity to induce
cytokine production by DCs.
EDN and hPR induced phenotypic and functional maturation of DCs
Activation of iDCs is usually accompanied by DC maturation. We therefore investigated
whether treatment of iDCs with EDN or hPR could induce maturation of DCs. Monocyte-
derived iDCs were incubated in G4 medium alone or in the presence of either EDN or hPR for
48 h and then investigated for their maturational status (Fig. 7). iDCs cultured in G4 medium
alone for 48 h maintained an immature phenotype (CD14−, CD40+, CD83−, CD86low, HLA-
DRhigh) (Fig. 7A, upper panel). In contrast, iDCs cultured in G4 plus hPR or EDN for 48 h,
although still CD14−, up-regulated the surface expression of CD83, CD86, and HLA-DR,
indicating that hPR and EDN treatment induced phenotypic maturation of DCs (Fig. 7A). In
contrast to hPR, EDN-treated DCs appeared to generate two subsets of DCs differing in levels
of surface CD83 and CD86 expression. This phenomenon was not due to donor variability
because cells from three independent donors demonstrated identical results.
The capacity of hPR or EDN to induce DC maturation was also evidenced by a change in
chemokine responsiveness of treated DCs (Fig. 7B). DCs cultured in G4 medium alone
migrated in response to RANTES, but not to SLC, indicating expression of functional CCR1
and/or CCR5, but not functional CCR7. However, DCs cultured in G4 in the presence of EDN
or hPR lost responsiveness to RANTES and acquired SLC-responsive CCR7. Because the
down-regulation of a number of chemokine receptors (including CCR1 and CCR5) and up-
regulation of functional CCR7 are another hallmark of DC maturation (36,37), these results
provide additional evidence that treatment with EDN or hPR induced the maturation of DCs.
To determine whether EDN- and hPR-induced maturation of DCs is also reflected at the
functional level, we determined whether EDN- or hPR-treated DCs could stimulate the
proliferation of allogeneic human peripheral blood T cells in an MLR assay. In contrast to
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medium-treated DCs that did not stimulate allogeneic T cells, both EDN- and hPR-treated DCs
stimulated the proliferation of allogeneic T lymphocytes in a concentration-dependent manner,
as judged by the increase of tritiated thymidine incorporation (Fig. 7C). Therefore, treatment
of iDCs with either EDN or hPR induces both phenotypic and functional maturation of DCs.
EDN expression by macrophages is inducible
The activating effects of EDN on DCs suggest that EDN has cytokine-like activities. A common
feature for all cytokines is inducibility, so we studied whether EDN expression can be up-
regulated. Besides being stored in eosinophil granules, EDN is also expressed by neutrophils
and macrophages (38,39). To investigate whether the expression of EDN by macrophages is
inducible, we treated human monocyte-derived macrophages with a combination of TNF-α
and LPS (both at 100 ng/ml) and measured EDN expression at both mRNA and protein levels
(Fig. 8). As shown by Fig. 8A, RT-PCR revealed that unstimulated macrophages displayed a
faint band (second lane, upper panel), confirming the previous report (39). Treatment of
macrophages with TNF-α plus LPS up-regulated the expression of EDN mRNA in a time-
dependent manner. EDN mRNA level began to increase at 30 min, peaked at 2 h, and subsided
gradually thereafter (Fig. 8A, upper panel). Amplification of GAPDH using the other half of
reverse-transcription products as template under identical PCR conditions yielded GAPDH
bands of nearly identical intensity, confirming that equal amounts of reverse-transcription
products were used in the PCR for EDN amplification (lower panel). Furthermore, Western
blot analysis (Fig. 8B) demonstrated that upon treatment by a combination of TNF-α and LPS
for 2 h, macrophage began to secrete EDN into the culture supernatant, which peaked at 8 h.
The EDN protein appeared as two bands of ~31 and 37 kDa, which were larger than the size
of rEDN (17.5 kDa, without glycosylation). The appearance of two bands larger than the rEDN
was due presumably to differential glycosylation of EDN because, using the same polyclonal
antiserum, Rugeles et al. (25) also found that EDN generated by cultured human PBMC appears
on a SDS-PAGE gel as bands of 31–40 kDa. Therefore, EDN expression by macrophages can
be rapidly induced.
Discussion
In the present study, we have shown that EDN (both natural and recombinant forms) and hPR
stimulated human CD34+ progenitor-derived and monocyte-derived DCs to produce a variety
of soluble mediators, including cytokines, chemokines, growth factors, and soluble receptors.
The soluble mediators induced by EDN and, to a lesser extent, hPR, consisted mostly of
proinflammatory cytokines and chemokines. In addition, treatment of human iDCs with EDN
or hPR also resulted in maturation of DCs, as evidenced by up-regulation of CD83, CD86, and
HLA-DR; switch of chemokine receptor expression from CCR5+ to CCR7+; and acquisition
of the capacity to stimulate allogeneic MLR. These activities of EDN and hPR were not due
to endotoxin contamination. Thus, both EDN and hPR can act as activators for DCs. This is
the first report that demonstrates EDN and hPR act as activator for DCs.
How EDN or hPR signals activation of DCs is currently under investigation. The chemotactic
effect of EDN on DCs is mediated by a pertussis toxin-sensitive Giα protein-coupled receptor
(GPCR) (26). We could not determine whether the DC-activating effect of EDN was also
mediated by a pertussis toxin-sensitive mechanism because pertussis toxin treatment of DCs
by itself induces the activation of DCs in vitro, leading to DC maturation and cytokine
production (40,41). It is unlikely that the capacity of EDN and hPR to activate DCs relies on
a pertussis toxin-sensitive GPCR-dependent mechanism because hPR is not chemotactic for
DCs (26). Conversely, although mEAR2, like EDN, is chemotactic for human DCs (26),
mEAR2 could not activate DCs to produce cytokines (Fig. 1). Another issue is whether EDN
and hPR use different mechanisms for the activation of DCs. Unlike EDN, hPR does not have
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either antiviral or chemotactic activities (18,24–26). Human ANG, another member of RNase
A superfamily that is evolutionarily more distant from EDN and hPR (18), also did not activate
DCs to produce any cytokines and chemokines (Fig. 6). Thus, these RNase A superfamily
members have essential functional differences, implying that EDN and hPR may use different
mechanisms to activate DCs.
hPR, produced in the pancreas and excreted into the gut, is believed to degrade the large
amounts of RNA present in food (19). The observation that hPR is also an activator of DCs
was unexpected. However, hPR is known to be expressed by tissues other than the pancreas
(19), including activated monocytes (39), α-galactosylceramide-stimulated monocyte-derived
DCs (42), and human endothelial cells from arteries, veins, and capillaries (43). Thus, hPR
may have nondigestive biological roles that have not been previously appreciated. Our results
suggest that hPR may contribute to inflammation. In vivo, hPR secretion is likely to be tightly
regulated. Consequently, the effect of hPR may not be evident unless it is quickly produced
and exposed to target cells in high amounts. Such is likely to be the case during acute
pancreatitis, a disorder that results from exposure of pancreatic parenchyma to digestive
enzymes, including hPR. It remains to be determined whether or not hPR is generated under
various inflammatory conditions.
EDN is a multifunctional mediator because it acts as an activator (present study) and a
chemoattractant of DCs (26), as well as an antiviral effector and an RNase (24,25). EDN, in
addition to being expressed by liver, spleen, neutrophils, and monocytes/macrophages (22,
38,39), is released in large amounts upon eosinophil degranulation (21,22). Furthermore, the
expression of EDN by macrophages is rapidly induced in response to TNF-α and LPS (Fig. 8).
Substantial infiltration and activation of eosinophils and monocytes/macrophages are most
often seen in tissues with helminth or viral infections and allergic and atopic reactions (18,
44). It is thus conceivable that EDN is produced at considerable levels at sites of inflammation
associated with such disorders. Based on its multifunctional activities, EDN may contribute to
both innate and adaptive antimicrobial immunity of the host. EDN may contribute to innate
immunity by killing/inactivating helminthic/viral invaders and inducing the production of
proinflammatory mediators to amplify local inflammatory responses. EDN may participate in
adaptive immunity in at least two ways. EDN may act synergistically with chemokines to
promote the recruitment of DCs to the sites of inflammation, hereby enhancing Ag uptake and
processing. Additionally, because it has the capacity to induce phenotypic and functional
maturation (Fig. 7), EDN may also contribute to promoting both the trafficking of DCs from
inflammatory sites to regional lymph nodes and the Ag presentation to naive T cells. This
suggests that the primary role of EDN is to eliminate the microbial invaders and restore host
homeostasis. Conversely, persistent generation of EDN in considerable amount may contribute
to the pathophysiology associated with eosinophil infiltration in asthma and other eosinophil-
associated diseases due to its capacity to cause DC recruitment and production of inflammatory
cytokines and chemokines.
Taking advantage of their RNase activities, both EDN and hPR have been used as fusion
partners of immunotoxins for experimental tumor therapy (45–47). In these studies, targeted
delivery of EDN or hPR into tumor cells causes the death of tumor cells both in vitro and in
vivo, the underlying mechanism of which is thought to be due to the degradation of RNAs of
tumor cells by EDN or hPR. The possibility that the DC-activating effects of EDN or hPR are
maintained by the fused immunotoxins has not been evaluated. It is therefore possible that
immunoadjuvant effects of EDN and hPR may contribute to the immunotherapeutic antitumor
effects of EDN- or hPR-based immunotoxins in immunocompetent mice.
In addition to EDN, a number of endogenous mediators, including defensins (4,5,8,9), high
mobility group box 1 (48), cathelicidins (3,6), aminoacyl-tRNA synthetases (49,50), urokinase
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(51,52), and ribosomal protein S19 (53), have also recently been shown to be chemotactic based
on interactions with GPCRs expressed by mononuclear leukocytes, including DCs, monocytes/
macrophages, and/or lymphocytes. These mediators are structurally diverse and distinct from
conventional chemokines because they are present in the intracellular compartment or on the
surface of keratinocytes and epithelial cell lining, where they function as enzymes, DNA-
binding protein, or antimicrobial effectors under normal or steady state. These mediators are
rapidly released or induced to produce in response to danger signals generated by tissue injury
or various (viral, bacterial, fungal, or parasitic) forms of infection. All of these mediators are
capable of stimulating the production of proinflammatory cytokines by monocytes/
macrophages and/or DCs, and some, such as murine β-defensin 2 (16), high mobility group
box 1 (48), and EDN (present study), have been shown to stimulate the maturation of DCs.
Because the recruitment and subsequent activation of monocytes/macrophages and DCs are
pivotal for the initiation of both innate and adaptive immune responses (37,54), these mediators
may function to mobilize and galvanize the immune system in response to danger signals.
Consequently, to aid in the recognition of these structurally diverse, but functionally similar
mediators, we propose to call them “endogenous multifunctional immune alarmins.”
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EDN and hPR induction of soluble mediator production by DCs. CD34+ progenitor-derived
iDCs (106/ml) were cultured in G4 medium alone or in the presence of EDN (1 μg/ml), mEAR2
(1 μg/ml), hPR (1 μg/ml), or TNF-α (100 ng/ml) for 16 h at 37°C in humidified air containing
5% CO2. A dozen of soluble mediators in the culture supernatants was measured by RCA
immunoassay, as described in Materials and Methods. The results are shown as fold induction,
which, for a given soluble mediator, was calculated by the formula: amount produced by DCs
in the presence of a stimulant/amount produced by DCs in G4 medium alone. IL-2sRa: soluble
IL-2R α-chain.
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Chemokine production induced by EDN (●) and hPR (▲) from CD34+ progenitor-derived
DCs. A, Time course; iDCs (106/ml) were cultured in G4 medium containing 1 μ g/ml EDN
or hPR for various time points, as specified. B, Dose response; iDCs (106/ml) were cultured
for 48 h in G4 medium in the absence or presence of various concentrations of EDN or hPR,
as specified. The culture supernatants were collected and measured by RCA immunoassay, as
described in Materials and Methods.
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Cytokine induction by EDN (●) and hPR (▲) from CD34+ progenitor-derived DCs. iDCs
(106/ml) were cultured in G4 medium containing 1 μg/ml recombinant EDN or hPR for various
times (A, time course) or for 48 h in G4 medium containing various concentrations of EDN or
hPR (B, dose response). The culture supernatants were collected and measured by RCA
immunoassay. Five cytokines induced by EDN or hPR are shown.
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ELISA confirmation of EDN-stimulated DC production of cytokines and chemokines. iDCs
generated from either bone marrow CD34+ progenitors (upper panel) or monocytes (lower
panel) were cultured in triplicate in the absence (□) or presence (■) of EDN at 1 μg/ml for 48
h. The supernatants were harvested for performance of ELISA measurement on seven
mediators, as indicated. Shown is the average (mean ± SD) of mediator production by
CD34+ cell-derived DCs from two (upper panel) and monocyte-derived DC from four (lower
panel) individuals.
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A, The effect of heating on the IL-6-inducing capacity of recombinant EDN or hPR. EDN,
hPR, and LPS samples were placed at 37°C or heated at 100°C for 30 min, followed by rapid
cooling down on ice before addition to CD34+ progenitor-derived iDCs (106/ml). The final
concentration for EDN, hPR, and LPS was 1 μg/ml, 1 μg/ml, and 100 ng/ml, respectively. After
incubation at 37°C for 24 h in humidified air containing 5% CO2, the supernatants were
collected and measured by ELISA for IL-6 production. B, Comparison of production of
mediators by CD34+ progenitor-derived iDCs cultured for 48 h in the presence of recombinant
EDN (1 μg/ml), hPR (1 μg/ml), and LPS (100 ng/ml). Only those mediators increased by ≥3-
fold over control levels were included.
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Comparison of the production of selected cytokines and chemokines by DCs in response to
various RNase samples. A, CD34+ progenitor-derived iDCs were incubated in G4 medium
alone or in the presence of natural (nEDN) or rEDN at 1 μg/ml at 37°C in humidified air
containing 5% CO2. After 48 h of culture, the supernatants were assayed for 10 selected
cytokines and chemokines by RCA immunoassay. The induction of cytokines and chemokines
is presented as fold increase, which was calculated by the following formula: fold increase =
Cy5 fluorescence in the presence of EDN or human pancreatic RNase/Cy5 fluorescence in the
absence of EDN or hPR. B, Monocyte-derived iDCs were incubated in triplicates in G4 medium
alone or in the presence of hPR, hANG, and natural and recombinant EDNs (at 1 μg/ml) at 37°
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C for 48 h in humidified air containing 5% CO2. The production of IL-6 and IL-4 chemokines
in the culture supernatants was measured by RCA immunoassay and shown as the average
(mean ± SEM) Cy5 fluorescence intensity. *, p < 0.05 when compared with G4-treated group.
Yang et al. Page 21














Induction of DC maturation by hPR and EDN. Monocyte-derived iDCs were incubated in G4
medium alone or in the presence of recombinant hPR or EDNs (at 1 μg/ml) at 37°C for 48 in
humidified air containing 5% CO2. The cells were collected and analyzed by flow cytometry,
chemotaxis assay, or allogeneic MLR, as described in Materials and Methods. A, Surface
expression of CD14, CD40, CD83, CD86, and HLA-DR by DCs cultured under conditions, as
specified. B, Comparison of the chemotatic responses of DCs cultured in the absence or
presence of 1 μg/ml EDN or hPR at 37°C for 48 h to optimal concentration (100 ng/ml) of
RANTES or SLC. C, Stimulation of the proliferation of allogeneic human peripheral blood T
lymphocytes by EDN- or hPR-treated DCs. T cells (105/well) were cultured in triplicate alone
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or with treated DCs at concentrations specified in 96-well plates for 7 days with the addition
of [3H]TdR (0.5 μCi/well) in the last 8 h of incubation. The cells were harvested and measured
for the incorporation of [3H]TdR (mean ± SD).
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Up-regulation of EDN expression by macrophages in response to TNF-α and LPS. A, Human
monocyte-derived macrophages were incubated in RPMI 1640 medium alone or in the presence
of a combination of LPS and human rTNF-α (each at 100 ng/ml) at 37°C in humidified air
containing 5% CO2 for a period of time, as indicated. Subsequently, total RNA was extracted
and used as the template for the amplification of EDN or GAPDH by RT-PCR, as described
in Materials and Methods. Upper and lower panels, EDN and GAPDH, respectively. B,
Macrophage culture supernatant was harvested under conditions as specified, and the amount
equivalent to 20 μg of protein was loaded onto each lane of a SDS-PAGE gel. rEDN (100 ng)
generated in E. coli was used as a control (last lane). After transfer, the polyvinylidene
difluoride membrane was blotted with rabbit anti-EDN polyclonal Ab, as detailed in Materials
and Methods.
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Table I
Comparison of mediator production by CD34+ cell-derived and monocyte-derived DCs in response to EDN or
hPRa
CD34+ Cell-Derived DCs Monocyte-Derived DCs
Mediatorsb EDN hPR EDN hPR
ENA-78 91 26 2 1
Eot2 1 1 3 3
I-309 4 3 4 1
IFN-α 1 1 5 0
IL-10 1 2 6 0
IL-12p40 32 4 3 1
IL-12p70 7 2 2 1
IL-13 1 2 3 1
IL-16 1 1 0 3
IL-6 182 74 181 15
IP-10 74 10 67 6
MCP-1 4 4 2 1
MCP-2 26 8 18 1
MCP-3 97 18 1 1
M-CSF 5 2 1 1
MIG 4 2 6 1
MIP-1α 14 7 10 2
MIP-1β 2 2 61 19
MPIF-1 3 2 6 6
NAP-2 4 2 2 1
RANTES 22 12 44 7
sCD23 2 3 1 1
TNF-α 25 5 10 1
sTNF-RI 3 2 1 2
a
CD34+ cell-derived and monocyte-derived iDCs were cultured at 37°C in humidified air containing 5% CO2 in G4 medium alone or G4 medium
plus EDN or hPR (both at 1 μg/ml) for 48 h. The culture supernatants were collected and stored at −70°C. The level of cytokines, chemokines, and
soluble receptors (a total of 78) in each supernatant was measured by RCA immunoassay and presented as fold increase, which was calculated by the
following formula: fold increase = Cy5 fluorescence in the presence of EDN or human pancreatic RNase/Cy5 fluorescence in the absence of EDN or
hPR. Only those with fold increase ≥3 by EDN or hPR are shown.
b
MPIF, Myeloid progenitor inhibitory factor; NAP, neutrophil-activating protein; s, soluble.
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